This research introduces a surface plasmon sensor utilizing photonic crystal fiber (PCF) for measuring glucose concentrations in urine. The sensor employs a configuration with TiO <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</inf> and gold as plasmonic materials, layered strategically to improve its performance. Simulation of the proposed sensor, using a finite element approach, focuses on detecting urine glucose levels. The setup involves applying a thin analyte layer onto the TiO <inf xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</inf> layer of the PCF to enable external sensing capabilities. Testing is conducted across four distinct glucose concentration levels: 0 gm / dL, 2.5 gm / dL, 5 gm / dL, 10 gm / dL, and 20 gm / dL, corresponding to refractive indices (RI) of $1.335,1.338,1.341,1.346$, and 1.358, respectively. A perfectly matched layer (PML) acts as the boundary condition for the topmost PCF layer. By adjusting geometrical parameters, an optimized structural design is achieved, resulting in a wavelength sensitivity of 3945.12 ~nm / RIU and an amplitude sensitivity of 438 RIU⁻¹ for 2.5 gm / dL. Experimental validation using various urine samples demonstrates superior accuracy and sensitivity compared to existing methods.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: